Crystal Whitby
Medical · Houston, TXNPI 1922325414
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.0% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 34.5% of the total. Reporting peaked in 2022 at $1,139 and has fallen 87.3% since, to $145 in 2025.
Across 160 payments — averaging $22.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$419
- E.r. Squibb & Sons, L.L.C.$243
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$178
- Johnson & Johnson$175
- Lilly USA, LLC$173
- plus $1K from 16 others
What the payments were for
- Speaking & faculty fees$842%
- Food & beverage$3,37194%
- Education$1304%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $1,236 |
| Novartis | 19 | $419 |
| E.r. Squibb & Sons, L.L.C. | 11 | $243 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 10 | $178 |
| Johnson & Johnson | 5 | $175 |
| Lilly USA, LLC | 7 | $173 |
| Sun Pharmaceutical Industries Inc. | 11 | $164 |
| VYNE Pharmaceuticals Inc. | 4 | $146 |
| Pfizer | 8 | $145 |
| Galderma Laboratories, L.p. | 5 | $127 |
| Incyte Corporation | 4 | $107 |
| LEO Pharma Inc. | 6 | $100 |
| EPI Health, LLC | 1 | $84 |
| Mentor Worldwide LLC | 2 | $70 |
| Amgen | 2 | $58 |
| Almirall LLC | 3 | $53 |
| Vertex | 1 | $25 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Sebela Pharmaceuticals Inc. | 1 | $15 |
| UCB, Inc. | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Skyrizi$129
- NATRELLE SALINE-FILLED BREAST IMPLANTS$125
- Sotyktu$122
- ZILXI$117
How this compares
$3,586 in reported general payments places this provider in the 80th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 16 | $251 |
Paid to pharmacies, not to this prescriber.
Other medical in Houston
- Olga RodziyenskaHouston$65K
- Kathleen HoganHouston$26K
- Omni McCluneyHouston$18K
- Carl MayberryHouston$18K
- Carley BuddenbaumHouston$16K
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.